Prospective natural history and clinical biomarkers of EYS-associated retinopathy in the KEYS study

Taniguchi M, Togashi Y, Yokota S, Hiraoka M, Kitahata S, Nakamura N, Yamamoto M, Mandai M, Gocho K, Toshimori M, Hirami Y, Gomi F, Kurimoto Y, Maeda A.

2026
Scientific Reports

View publication

Therapeutic Area

Back of the eye (BOTE)
Categories

Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…), Sponsored/funded by Santen

Affiliations

Hyogo Medical University Hospital, Nishinomiya, Japan. hirota.mrk@gmail.com.; Kobe City Eye Hospital, Kobe, Japan. hirota.mrk@gmail.com.; Santen Pharmaceutical Co., Ltd, Osaka, Japan; Kobe City Eye Hospital, Kobe, Japan; Kobe City Medical Center General Hospital, Kobe, Japan; Yokohama City University Medical Center, Yokohama, Japan; Quinze-Vingts National Eye Hospital, Paris, France; Hyogo Medical University Hospital, Nishinomiya, Japan.

Related Publications

STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24‑Month Results of a Randomized, Double‑Masked, Vehicle‑Controlled Trial of Atropine Sulfate 0.01% and 0.03%

Korenfeld M.; Hurcikova M.; Tatsuoka K.; Cheetham J.; Kacerik M.; on behalf of the STAR Study Investigators

Consensus on evidence gaps and unmet needs in childhood myopia: findings from a European Delphi study with eye care professionals and payers

Lagreze W, Nucci P, Versteegh M, Klaver C, Barrio-Barrio J, Dahlmann-Noor A, Gomez de Liaño R, Ghorbani-Mojarrad N, Kessel L, Polling JR, Sauer A, Schuster AK, Serafino M, Villani E, Ziemssen F, Boehler YB, Capri S, Gianfrate F, Valles Callol JA, Wong O, Chen TY, Lymperopoulou C, Palaka I, Punekar Y, von Bredow D, Shi-van Wielink K.

Economic evaluation, resource utilisation, and associated economic burden of myopia management: a systematic literature review

de Milliano T. WL, Shi-van Wielink K., Ernst F., Mulkalapalli N., Pagidigummula R., Lymperopoulou C.

View all Back of the eye (BOTE) publications